Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host

2020 New England Journal of Medicine 1,337 citations

Abstract

SARS-CoV-2 in an Immunocompromised Host This letter describes an immunocompromised patient who had persistent infection with SARS-CoV-2 over a period of months, despite several courses of remdesivi...

Keywords

Persistence (discontinuity)Host (biology)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakVirologyBiologyMedicineGeneticsInfectious disease (medical specialty)DiseasePathologyOutbreak

Affiliated Institutions

Related Publications

SARS-CoV-2 vaccines in development

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in late 2019 in China and is the causative agent of the coronavirus disease 2019 (COVID-19) pande...

2020 Nature 2193 citations

Publication Info

Year
2020
Type
letter
Volume
383
Issue
23
Pages
2291-2293
Citations
1337
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

1337
OpenAlex

Cite This

Bina Choi, Manish C. Choudhary, James Regan et al. (2020). Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host. New England Journal of Medicine , 383 (23) , 2291-2293. https://doi.org/10.1056/nejmc2031364

Identifiers

DOI
10.1056/nejmc2031364